PIN8 a Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without "Tenofovir Add-on as Needed" and Lamivudine with or without "Tenofovir Add-on as Needed" in the Treatment of Chronic Hepatitis B Infection in Turkey
Ozdemir, O.; Saylan, M.; Pakel, H.; Lescrauwaet, B.
Value in Health 14(7): A266-A267
2011
ISSN/ISBN: 1098-3015 Document Number: 207260
Document emailed within 1 workday
Related Documents
Mauss, S.; Milinkovic, A.; Hoffmann, C.; Holm, S.; Berger, F.; Martínez, E.; Kuhlmann, B.; Gatell, J.é; Schmutz, G. 2005: Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine Aids 19(1): 101-102Snopková, S.; Havlíčková, K.ři.; Husa, P. 2016: Tenofovir alafenamide fumarate - a new generation of tenofovir Klinicka Mikrobiologie a Infekcni Lekarstvi 22(3): 111-117
Baeten, J.M.; Donnell, D.; Mugo, N.R.; Ndase, P.; Thomas, K.K.; Campbell, J.D.; Wangisi, J.; Tappero, J.W.; Bukusi, E.A.; Cohen, C.R.; Katabira, E.; Ronald, A.; Tumwesigye, E.; Were, E.; Fife, K.H.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Kidoguchi, L.; Coombs, R.W.; Hendrix, C.; Marzinke, M.A.; Frenkel, L.; Haberer, J.E.; Bangsberg, D.; Celum, C. 2014: Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial Lancet. Infectious Diseases 14(11): 1055-1064
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Verhelst, D.; Goffin, E. 2000: Lamivudine for the treatment of chronic hepatitis B New England Journal of Medicine 342(8): 592
Zoulim, F. 2000: Long-term treatment with lamivudine for chronic hepatitis B Gastroenterologie Clinique et Biologique 24(12): 1153-1154
Gibb, D.M.; Kizito, H.; Russell, E.C.; Chidziva, E.; Zalwango, E.; Nalumenya, R.; Spyer, M.; Tumukunde, D.; Nathoo, K.; Munderi, P.; Kyomugisha, H.; Hakim, J.; Grosskurth, H.; Gilks, C.F.; Walker, A.S.; Musoke, P.; Grosskurth, H.; Munderi, P.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Mugisha, A.; Todd, J.; Levin, J.; Muyingo, S.; Ruberantwari, A.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Lyagoba, F.; Hughes, P.; Aber, M.; Medina Lara, A.; Foster, S.; Amurwon, J.; Nyanzi Wakholi, B.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Fadhiru, K.; Nsibambi, D.; Nahirya-Ntege, 2012: Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial PLOS Medicine 9(5): E1001217
Sheldon, J.; Camino, N.; Rodés, B.; Bartholomeusz, A.; Kuiper, M.; Tacke, F.; Núñez, M.; Mauss, S.; Lutz, T.; Klausen, G.; Locarnini, S.; Soriano, V. 2005: Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir Antiviral Therapy 10(6): 727-734
Marrazzo, J.M.; Ramjee, G.; Richardson, B.A.; Gomez, K.; Mgodi, N.; Nair, G.; Palanee, T.; Nakabiito, C.; van der Straten, A.; Noguchi, L.; Hendrix, C.W.; Dai, J.Y.; Ganesh, S.; Mkhize, B.; Taljaard, M.; Parikh, U.M.; Piper, J.; Mâsse, Bît.; Grossman, C.; Rooney, J.; Schwartz, J.L.; Watts, H.; Marzinke, M.A.; Hillier, S.L.; McGowan, I.M.; Chirenje, Z.Mike.; Chirenje, Z.Mike.; Marrazzo, J.; Bragg, V.; Gomez, K.; Horn, S.; Levy, L.; Mayo, A.; Moore, A.T.; Richards, K.; Schwartz, K.; White, R.; Torjesen, K.; Borgerding, J.; Gandham, S 2015: Tenofovir-based preexposure prophylaxis for HIV infection among African women New England Journal of Medicine 372(6): 509-518
Sarin, S.K.; Kumar, M.; Hissar, S.; Sharma, B.C. 2006: Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(3): 374-380
Abdool Karim, Q.; Abdool Karim, S.S.; Frohlich, J.A.; Grobler, A.C.; Baxter, C.; Mansoor, L.E.; Kharsany, A.B.M.; Sibeko, S.; Mlisana, K.P.; Omar, Z.; Gengiah, T.N.; Maarschalk, S.; Arulappan, N.; Mlotshwa, M.; Morris, L.; Taylor, D.; Abdool Karim, K.; Abdool Karim, S.S.; Frohlich, J.A.; Kharsany, A.B.M.; Mlisana, K.P.; Baxter, C.; Mansoor, L.E.; Arulappan, N.A.; Maarschalk, S.; Humphries, H.; Parker, G.; Richards, J.; Upton, J.; Sibeko, S.; Mdluli, B.; Miya, N.; Mtongana, L.; Naicker, N.; Omar, Z.; Sokal, D.; Chetty, D.D.; Dlamini, F.; Gumede, S.D.; Gumede, Z.; Khambule, N.E.; Langa, N.; Madlala, B.T.; Madlala, N.; Mkhize, N.; Mkhize, Z.L.; Mlotshwa, M. 2010: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329(5996): 1168-1174
Piketty, C.; Gérard, L.; Chazallon, C.; Marcelin, A.-G.èv.; Clavel, F.ço.; Taburet, A.-M.; Calvez, V.; Madelaine-Chambrin, I.; Molina, J.-M.; Aboulker, J.-P.; Girard, P.-M. 2006: Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial Antiviral Therapy 11(2): 213-221
Terris-Prestholt, F.; Foss, A.M.; Cox, A.P.; Heise, L.; Meyer-Rath, G.; Delany-Moretlwe, S.; Mertenskoetter, T.; Rees, H.; Vickerman, P.; Watts, C.H. 2014: Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices Bmc Infectious Diseases 14: 14
Fung, J.; Lai, C.-L.; Yuen, J.C.-h.; Wong, D.K.-H.; Tanaka, Y.; Mizokami, M.; Yuen, M.-F. 2007: Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population Antiviral Therapy 12(1): 41-46
Mesquita, P.M.M.; Rastogi, R.; Segarra, T.J.; Teller, R.S.; Torres, N.Merna.; Huber, A.M.; Kiser, P.F.; Herold, B.C. 2012: Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection Journal of Antimicrobial ChemoTherapy 67(7): 1730-1738
Sampaio, C.; Ferreira, J.; Costa, J. 2000: Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 19(12): 1303-1308
Kashuba, A.D.M.; Gengiah, T.N.; Werner, L.; Yang, K.-H.; White, N.R.; Karim, Q.A.; Abdool Karim, S.S. 2015: Genital Tenofovir Concentrations Correlate with Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness Journal of Acquired Immune Deficiency Syndromes 69(3): 264-269
Annicchiarico, B.E.; Siciliano, M.; Gasbarrini, A. 2012: Chronic hepatitis C virus infection: clinical picture and treatment possibilities Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(Suppl 54): S103-S108
Robinson, N. 2000: Treatment options needed Journal of the American Veterinary Medical Association 216(11): 1715-1716
Vandepitte, W.P.; Ponthong, R.; Srisarang, S. 2015: Treatment Outcomes of the Uncomplicated Upper Respiratory Tract Infection and Acute Diarrhea in Preschool Children Comparing those with and without Antibiotic Prescription Journal of the Medical Association of Thailand 98(10): 974-984